Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
48.5M
-
Shares change
-
+3.32M
-
Total reported value, excl. options
-
$85.3M
-
Value change
-
+$4.46M
-
Put/Call ratio
-
2.96
-
Number of buys
-
58
-
Number of sells
-
-39
-
Price
-
$1.76
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q1 2021
127 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q1 2021.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.5M shares
of 237M outstanding shares and own 20.47% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (16.6M shares), Nuveen Asset Management, LLC (6.76M shares), BlackRock Inc. (5.75M shares), VANGUARD GROUP INC (4.15M shares), GEODE CAPITAL MANAGEMENT, LLC (1.36M shares), STATE STREET CORP (1.01M shares), NORTHERN TRUST CORP (793K shares), Maven Securities LTD (750K shares), Schonfeld Strategic Advisors LLC (692K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (690K shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.